PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.07%
Revenue growth at 50-75% of ON's 5.97%. Martin Whitman would worry about competitiveness or product relevance.
6.28%
Gross profit growth under 50% of ON's 15.46%. Michael Burry would be concerned about a severe competitive disadvantage.
8.28%
EBIT growth 50-75% of ON's 15.66%. Martin Whitman would suspect suboptimal resource allocation.
8.59%
Operating income growth at 50-75% of ON's 15.66%. Martin Whitman would doubt the firm’s ability to compete efficiently.
9.81%
Net income growth under 50% of ON's 37.52%. Michael Burry would suspect the firm is falling well behind a key competitor.
9.48%
EPS growth under 50% of ON's 37.50%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
9.66%
Diluted EPS growth under 50% of ON's 37.14%. Michael Burry would worry about an eroding competitive position or excessive dilution.
0.11%
Share count expansion well above ON's 0.12%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
No Data
No Data available this quarter, please select a different quarter.
12.62%
Dividend growth of 12.62% while ON is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-2.92%
Negative OCF growth while ON is at 39.59%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-44.64%
Negative FCF growth while ON is at 27.92%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
73.70%
10Y revenue/share CAGR under 50% of ON's 151.12%. Michael Burry would suspect a lasting competitive disadvantage.
52.56%
5Y revenue/share CAGR 1.25-1.5x ON's 41.71%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
34.08%
3Y revenue/share CAGR above 1.5x ON's 18.77%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
198.43%
10Y OCF/share CAGR at 50-75% of ON's 297.39%. Martin Whitman might fear a structural deficiency in operational efficiency.
83.17%
5Y OCF/share CAGR at 50-75% of ON's 164.40%. Martin Whitman would question if the firm lags in monetizing revenue effectively.
13.33%
3Y OCF/share CAGR under 50% of ON's 43.93%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
782.06%
Net income/share CAGR at 50-75% of ON's 1146.75%. Martin Whitman might question if the firm’s product or cost base lags behind.
120.11%
Below 50% of ON's 271.75%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
77.97%
3Y net income/share CAGR 50-75% of ON's 148.71%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
49.67%
Below 50% of ON's 226.22%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
37.23%
Below 50% of ON's 143.45%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
52.90%
3Y equity/share CAGR 1.25-1.5x ON's 39.81%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
576.51%
Dividend/share CAGR of 576.51% while ON is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
129.41%
Dividend/share CAGR of 129.41% while ON is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
48.82%
3Y dividend/share CAGR of 48.82% while ON is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
2.90%
AR growth is negative/stable vs. ON's 12.42%, indicating tighter credit discipline. David Dodd confirms it doesn't hamper actual sales.
2.52%
Inventory growth well above ON's 3.91%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
6.03%
Asset growth at 75-90% of ON's 7.66%. Bill Ackman suggests reviewing opportunities to match or surpass the competitor's asset expansion if profitable.
9.61%
75-90% of ON's 10.97%. Bill Ackman advocates improvements in profitability or buybacks to keep pace in net worth growth.
6.03%
We have some new debt while ON reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
0.26%
R&D dropping or stable vs. ON's 3.95%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
-1.94%
We cut SG&A while ON invests at 6.66%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.